CNR Core Natural Resources, Inc. Insider Trading

SVP, CLO & Corp. Sec. Rosemary L Klein sold 15,000 shares (15.0K) for $1.6M at Core Natural Resources at blended avg $106.87

Klein Rosemary L, as SVP, CLO & Corp. Sec., executed 2 separate sales totaling 15,000 shares (15.0K shares) for $1,603,100.00 ($1.6M) on 2026-03-19, reducing her holdings by -21.8% to 53,679 shares (53.7K shares). The sales occurred at prices ($105.00 and $110.62 per share) near the current price of $107.17 and the 52-week high, in an environment where the stock is at its 52-week peak (+0.0% from 52-week high) and has risen sharply (+20.5% over 30 days, +21.3% over 90 days). The company reported latest quarterly revenue of $1,002,543,000.00 ($1.0B) with annual revenue growth of +92.4%, though it remained unprofitable on a full-year basis (negative full-year net income), signaling that rapid revenue expansion has not yet translated to profitability. A significant reduction in holdings by a senior legal and compliance officer at a company approaching profitability inflection while trading at multi-year highs warrants investor attention to understand management's confidence in the current valuation.

CEO Brock James A sells 40,760 shares ($4.1M) at $101.15; stock now 0.0% from 52-week high of $107.10

Brock James A, Executive Chair and CEO of Core Natural Resources, sold 40,760 shares at $101.15 on 2026-03-18, reducing his holdings from 140,760 to 100,000 shares—a -29.0% reduction in his position. The sale occurred at $101.15 while the stock's current price is $107.10, placing the transaction 5.5% below the current 52-week high. The company posted $1.0B in quarterly revenue with +92.4% annual revenue growth, though it remains unprofitable on a full-year basis with negative net income. Across his cross-ticker track record of 17 prior open-market sells, his timing has been weak: average 90-day returns of -3.3% (indicating stock typically rose after his sales) with a 41.18% well-timed rate, below the performance threshold that would suggest consistent predictive accuracy. The stock has appreciated +23.7% in the 30 days and +21.2% in the 90 days preceding this sale.

CEO Lang purchases 7,500 shares of CNR at $66.95; stock down -32.9% from 52-week high, company reports -$69.3M net loss.

CEO Paul A Lang purchased 7,500 shares at $66.95 on 2025-05-09, increasing his holdings to 341,062 shares, while the stock trades at $68.41, having declined -32.9% from its 52-week high of $101.91 and fallen -19.7% over the past 90 days. Core Natural Resources reported a net loss of -$69.3M in the latest quarter alongside an annual revenue decline of -13.0%, presenting a deteriorating operational backdrop. The purchase occurs in a challenged valuation environment (P/E of 31.24) where the stock faces downward momentum, though the absolute dollar commitment of $502,125.00 is modest relative to the CEO's existing 333,562-share position. Without visibility into whether this trade is scheduled or discretionary, the timing and magnitude alone do not provide a strong directional signal on management conviction amid operationally negative results.

CEO Brock James A sells 17,398 shares for $1.75M across 8 trades (Jun 27–28), blended avg $100.85; current price $107.31

Brock James A, CEO of CONSOL Energy (CEIX), executed 8 separate sales totaling 17,398 shares for $1,754,548.48 across June 27–28, 2024, at a blended average price of $100.85 per share. This represents a -3.3% reduction in his holdings to 513,789 shares. The stock is now trading at $107.31, placing these sales approximately 6% below the current price. His prior 5 CEIX-specific sales show consistent patterns: all 3 with measurable 90-day outcomes were well-timed (30-day declines of -1.3% to -2.2%, 90-day declines of -18.7% to -19.6%), and his cross-ticker track record across 9 open-market sells reflects a 100.00% well-timed rate at the 90-day mark with an average 90-day return of -18.3%. The fundamental backdrop shows CEIX trading at a P/E of 5.98 with strong recent momentum (+29.6% over 90 days, +3.5% over 30 days) and healthy financials (Revenue $565.0M, Net income $101.9M, Annual revenue growth +22.2%). The timing of these sales—executed near the 52-week high ($113.09) and concurrent with positive price momentum—combined with the insider's demonstrated pattern of well-timed prior exits, warrants close monitoring of upcoming catalysts and forward guidance.